April 20, 2014 11:03 PM ET

Pharmaceuticals

Company Overview of OSI Pharmaceuticals Inc.

Company Overview

OSI Pharmaceuticals Inc., an oncology drug discovery and translational research company, primarily focuses on the discovery of molecular targeted therapies. The company offers Tarceva, which treats non-small cell lung cancer. It develops OSI-906, a small-molecule and dual kinase inhibitor of insulin-like growth factor-1 receptor and insulin receptor for lung and ovarian cancers. The company develops OSI-027, a mammalian target of rapamycin kinase inhibitor that inhibits the kinase activity associated with the TORC1 and TORC2 complexes of mTOR. The company was formerly known as Oncogene Science Inc. and changed its name to OSI Pharmaceuticals Inc. in October 1997. The company was founded in 1...

1 Bioscience Park Drive

Farmingdale, NY 11735

United States

Founded in 1983

512 Employees

Phone:

631-962-0600

Fax:

631-845-5671

Key Executives for OSI Pharmaceuticals Inc.

Chief Financial Officer
Age: 52
Executive Vice President and President of Pharmaceutical Business
Age: 51
Senior Vice President
Age: 50
Interim Head of Oncology Development
Age: 56
Senior Vice President of Research and Development Diabetes & Obestity
Age: 47
Compensation as of Fiscal Year 2013.

OSI Pharmaceuticals Inc. Key Developments

OSI Pharmaceuticals Inc. Lays Off 115 Local Employees

OSI Pharmaceuticals Inc. announced that it is shuttering its remaining facility in the Long Island region and laying off all 115 of its local employees. The company said that it was closing the facility, located on the campus of Farmingdale State College. Most employees were dismissed immediately; a handful will stay to close the labs over the next four months. The workers will receive severances and continue to be paid for 90 days in accordance with state law. The closure is part of a global consolidation at Astellas, which is also shuttering facilities in Silicon Valley and suburban Chicago, cutting a total of 200 jobs.

Similar Private Companies By Industry

Company Name Region
Errant Gene Therapeutics, LLC United States
NutraCea/Cura, LLC United States
American Health Sciences United States
Adynxx, Inc United States
Innovative Custom Products, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OSI Pharmaceuticals Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.